This experiment took place over 56 weeks and was considered a phase 3a, open-label, parallel-group, randomized controlled trial that included 813 participants diagnosed with type 2 diabetes being actively treated with oral antidiabetic drugs
Vasculotoxic and proinflammatory effects of plasma heme: cell signaling and cytoprotective responses
Lau J, Bloch P, Schaffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB, et al
Frequently Asked Questions What is the best injection site for tirzepatide to reduce nausea
Storer, Thomas W et al